SOM alum Emilia Javorsky on Forbes ‘30 Under 30’ list

By Ellie Castano

UMass Medical School Communications

January 11, 2017
  Emilia Javorsky, MD, MPH

Emilia Javorsky, MD, MPH

Emilia Javorsky, MD, MPH, a 2014 graduate of the School of Medicine, was named to Forbes’ 30 Under 30 Healthcare list for 2017. Dr. Javorsky is a research fellow in the lab of Rox Anderson, MD, at Massachusetts General Hospital and Harvard Medical School, where she leads invention, development and translation of new therapies into clinical practice.

Javorsky was recognized by Forbes for her work as a physician-scientist for developing with her colleague Lilit Garibyan, MD, PhD, a biocompatible coolant that serves as a minimally invasive method of removing fat from any anatomical area. The method has potential therapeutic applications for type 2 diabetes and sleep apnea. It is also being investigated as a potential treatment for select neuropathic pain syndromes.

“My time at UMMS was transformative and enabled me to become the health innovator I am today,” said Javorsky, who earned an MPH from Boston University prior to enrolling in medical school.

She became a translational researcher to better understand how advances in science and technology can be used to solve fundamentally human problems.

“I believe this interplay can become a positive feedback loop of innovation, where technologic solutions to practical problems enable us to lead a more thoughtful and creative existence. This opportunity is especially exciting in medicine,” said Javorsky. “Breakthroughs in biology, which are happening at an ever quickening pace, must be integrated into an increasingly complex health care ecosystem. Successful integration hinges on the strategic use of technology both to transform basic scientific findings into game-changing therapies, and to improve the health care system.”

In addition to her research and commercialization efforts, Javorsky is part of a team developing a curriculum to teach problem-based innovation to clinicians to engage and empower them to participate in the medical innovation process.

For the Media
▴ Back To Top
Section Menu To Top